1. Home
  2. Stocks
  3. NASDAQ
  4. PODD

Logo of Insulet (NASDAQ:PODD)Latest Insulet (NASDAQ:PODD) News

Page 1
Page 1 of 1
Insulet’s Omnipod momentum funds a US$1 billion shareholder return

Insulet lifts margin outlook as Omnipod growth nears 20% and $1 billion buyback begins

Insulet delivered a stronger-than-expected third quarter, with revenue up 19.2% and adjusted earnings per share rising nearly 60%. The diabetes-device maker also raised its operating-margin outlook and authorised a US$1 billion share repurchase programme.
Ada Torres
4 Nov 2026